Molecular design, synthesis, and structure–Activity relationships leading to the potent and selective p56lck inhibitor BMS-243117
Jagabandhu Das, James C. Lin, Robert V. Moquin et al. · Bioorganic & Medicinal Chemistry Letters · 2003
Cited by 58 works. doi:10.1016/s0960-894x(03)00380-9
Authors
- Jagabandhu Das
- James C. Lin
- Robert V. Moquin
- Zhongqi Shen
- Steven H. Spergel
- John Wityak
- Arthur M. Doweyko
- Henry F. DeFex
- Suhong Pang
- Sidney Pitt
- Ding Ren Shen
- Gary L. Schieven
- Joel C. Barrish
References
- Signal transduction by lymphocyte antigen receptors
- Discovery of a Novel, Potent, and Src Family-selective Tyrosine Kinase Inhibitor
- Genetic evidence for the involvement of the lck tyrosine kinase in signal transduction through the T cell antigen receptor
- Profound block in thymocyte development in mice lacking p56lck
- Structural basis for activation of human lymphocyte kinase Lck upon tyrosine phosphorylation
- The Role of Protein Tyrosine Kinases and Protein Tyrosine Phosphatases in T Cell Antigen Receptor Signal Transduction
- A dominant‐negative transgene defines a role for p56lck in thymopoiesis.
- Structural analysis of the lymphocyte-specific kinase Lck in complex with non-selective and Src family selective kinase inhibitors
- αβ T Cell Development Is Abolished in Mice Lacking Both Lck and Fyn Protein Tyrosine Kinases
- Pyrrolo[2,3-d]pyrimidines containing an extended 5-substituent as potent and selective inhibitors of lck I